These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 10519422

  • 1. Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells.
    Rizzo MT, Regazzi E, Garau D, Akard L, Dugan M, Boswell HS, Rizzoli V, Carlo-Stella C.
    Cancer Res; 1999 Oct 01; 59(19):5047-53. PubMed ID: 10519422
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Specificity of arachidonic acid-induced inhibition of growth and activation of c-jun kinases and p38 mitogen-activated protein kinase in hematopoietic cells.
    Rizzo MT, Pudlo N, Farrell L, Leaver A.
    Prostaglandins Leukot Essent Fatty Acids; 2002 Jan 01; 66(1):31-40. PubMed ID: 12051955
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X, Jin Y, Cheng C, Zhang H, Zou W, Zheng Q, Lu Z, Chen Q, Lai Y, Pan J.
    Clin Cancer Res; 2009 Mar 01; 15(5):1686-97. PubMed ID: 19240172
    [Abstract] [Full Text] [Related]

  • 8. Antileukemic activity of lysophosphatidic acid acyltransferase-beta inhibitor CT32228 in chronic myelogenous leukemia sensitive and resistant to imatinib.
    La Rosée P, Jia T, Demehri S, Härtel N, de Vries P, Bonham L, Hollenback D, Singer JW, Melo JV, Druker BJ, Deininger MW.
    Clin Cancer Res; 2006 Nov 01; 12(21):6540-6. PubMed ID: 17085669
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells.
    Taniguchi S, Dai CH, Krantz SB.
    Exp Hematol; 1997 Mar 01; 25(3):193-8. PubMed ID: 9091293
    [Abstract] [Full Text] [Related]

  • 11. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV, Gerasimova LP, Sarkisian GP, Borovkova TV, Dukhovenskaia EA, Manakova TE, Naĭdenova NM, Timofeev AM, Grineva NI.
    Tsitologiia; 2007 Mar 01; 49(10):889-900. PubMed ID: 18074781
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells.
    Huang M, Dorsey JF, Epling-Burnette PK, Nimmanapalli R, Landowski TH, Mora LB, Niu G, Sinibaldi D, Bai F, Kraker A, Yu H, Moscinski L, Wei S, Djeu J, Dalton WS, Bhalla K, Loughran TP, Wu J, Jove R.
    Oncogene; 2002 Dec 12; 21(57):8804-16. PubMed ID: 12483533
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS, Liu DS, Dai CW, Li RJ.
    Am J Hematol; 2006 Apr 12; 81(4):242-55. PubMed ID: 16550520
    [Abstract] [Full Text] [Related]

  • 15. Anti-leukemic activity of valproic acid and imatinib mesylate on human Ph+ ALL and CML cells in vitro.
    Kircher B, Schumacher P, Petzer A, Hoflehner E, Haun M, Wolf AM, Nachbaur D, Gastl G.
    Eur J Haematol; 2009 Jul 12; 83(1):48-56. PubMed ID: 19226363
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
    Wilson MB, Schreiner SJ, Choi HJ, Kamens J, Smithgall TE.
    Oncogene; 2002 Nov 21; 21(53):8075-88. PubMed ID: 12444544
    [Abstract] [Full Text] [Related]

  • 18. Functional integrity in vitro of hematopoietic progenitor cells from patients with chronic myeloid leukemia that have achieved hematological remission after different therapeutic procedures.
    Chávez-González A, Ayala-Sánchez M, Sánchez-Valle E, Ruiz-Sánchez E, Arana-Trejo RM, Vela-Ojeda J, Mayani H.
    Leuk Res; 2006 Mar 21; 30(3):286-95. PubMed ID: 16111748
    [Abstract] [Full Text] [Related]

  • 19. The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro.
    Korycka A, Robak T.
    Arch Immunol Ther Exp (Warsz); 2003 Mar 21; 51(1):61-7. PubMed ID: 12691305
    [Abstract] [Full Text] [Related]

  • 20. Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors.
    Thijsen SF, Schuurhuis GJ, van Oostveen JW, Theijsmeijer AP, van der Hem KG, Odding JH, Dräger AM, Ossenkoppele GJ.
    Br J Cancer; 1999 Mar 21; 79(9-10):1406-12. PubMed ID: 10188883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.